ArticlePharmaceuticals (Basel, Switzerland)2022

A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca

Jingyun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.